1. Home
  2. RSLS vs SGN Comparison

RSLS vs SGN Comparison

Compare RSLS & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSLS
  • SGN
  • Stock Information
  • Founded
  • RSLS 2002
  • SGN 2019
  • Country
  • RSLS United States
  • SGN United States
  • Employees
  • RSLS N/A
  • SGN N/A
  • Industry
  • RSLS Medical/Dental Instruments
  • SGN
  • Sector
  • RSLS Health Care
  • SGN
  • Exchange
  • RSLS Nasdaq
  • SGN Nasdaq
  • Market Cap
  • RSLS 4.5M
  • SGN 3.8M
  • IPO Year
  • RSLS 2007
  • SGN 2023
  • Fundamental
  • Price
  • RSLS $2.56
  • SGN $1.13
  • Analyst Decision
  • RSLS Hold
  • SGN
  • Analyst Count
  • RSLS 1
  • SGN 0
  • Target Price
  • RSLS N/A
  • SGN N/A
  • AVG Volume (30 Days)
  • RSLS 7.3M
  • SGN 12.3M
  • Earning Date
  • RSLS 08-13-2025
  • SGN 08-18-2025
  • Dividend Yield
  • RSLS N/A
  • SGN N/A
  • EPS Growth
  • RSLS N/A
  • SGN N/A
  • EPS
  • RSLS N/A
  • SGN N/A
  • Revenue
  • RSLS $7,175,000.00
  • SGN $529,282.00
  • Revenue This Year
  • RSLS $52.80
  • SGN N/A
  • Revenue Next Year
  • RSLS N/A
  • SGN N/A
  • P/E Ratio
  • RSLS N/A
  • SGN N/A
  • Revenue Growth
  • RSLS N/A
  • SGN 8.42
  • 52 Week Low
  • RSLS $2.23
  • SGN $0.44
  • 52 Week High
  • RSLS $414.99
  • SGN $36.70
  • Technical
  • Relative Strength Index (RSI)
  • RSLS 36.91
  • SGN 52.46
  • Support Level
  • RSLS $2.45
  • SGN $0.92
  • Resistance Level
  • RSLS $2.87
  • SGN $1.11
  • Average True Range (ATR)
  • RSLS 0.68
  • SGN 0.22
  • MACD
  • RSLS 0.14
  • SGN -0.04
  • Stochastic Oscillator
  • RSLS 5.45
  • SGN 21.78

About RSLS ReShape Lifesciences Inc.

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.

About SGN Signing Day Sports Inc.

Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.

Share on Social Networks: